Table 1.
Demographic characteristics and comorbidities of patients with COVID-19 according to the presence/absence of HF.
| Variables | All Patients N = 3260 n (%) |
Without HF N = 3078 n (%) |
With HF N = 182 n (%) |
p-Value 1 |
|---|---|---|---|---|
| Age (y), median (IQR) | 61 (48.0, 71.0) | 60 (48.0, 70.0) | 71 (60.0, 78.8) | <0.001 |
| Male, n (%) | 2059 (63.2) | 1944 (63.2) | 115 (63.2) | >0.9 |
| Comorbidities | ||||
| Arterial hypertension | 1596 (49.0) | 1464 (47.6) | 132 (72.5) | <0.001 |
| Diabetes mellitus | 869 (26.7) | 785 (25.5) | 84 (46.2) | <0.001 |
| Overweight/obesity | 1621 (49.7) | 1540 (50) | 81 (44.5) | 0.2 |
| Coronary heart disease | 244 (7.5) | 163 (5.3) | 81 (44.4) | <0.001 |
| Atrial fibrillation | 115 (3.5) | 65 (2.1) | 50 (27.5) | <0.001 |
| Dyslipidemia | 451 (13.8) | 389 (12.6) | 62 (34.1) | <0.001 |
| Chronic lung disease/asthma | 287 (8.8) | 256 (8.3) | 31 (17) | <0.001 |
| Chronic kidney disease | 270 (8.3) | 223 (7.3) | 47 (25.7) | <0.001 |
| Cancer | 139 (4.3) | 127 (4.1) | 12 (6.6) | 0.2 |
| Cerebrovascular event | 102 (3.1) | 92 (3.0) | 10 (5.5) | 0.10 |
| HIV infection | 24 (0.7) | 24 (0.8) | 0 (0.0) | 0.5 |
| Smoking | 438 (13.4) | 386 (12.5) | 52 (28.6) | <0.001 |
1 Wilcoxon rank sum test; Pearson’s Chi-squared test. HF: heart failure. HIV: human immunodeficiency virus. IQR: interquartile range. n: number of patients. y: years.